Back to Test Catalogue

Imipramine and Desipramine, Serum/Plasma

Test ID: IMI

Test

Method

LC-MS/MS

Report Includes

Imipramine; Desipramine; Imipramine + Desipramine

Specimens

Avoid gel separator tubes; Serum; Plasma (EDTA)

Test Location

St. Michael's Hospital, 30 Bond Street, Toronto ON M5B 1W8

Test Version

17-Oct-2022

Specimen

Specimens

Avoid gel separator tubes; Serum; Plasma (EDTA)

Sample Volume

3 mL

Specimen Comment

Avoid gel separator tubes.

Collection & Handling

Collection Instructions

Collect trough specimen (i.e. collected within 1 hours prior to next dose or at least 12 hours after last dose.)

Handling Information

Separate as soon as possible.

Stability

Ambient 5 days
Refrigerated 2 weeks
Frozen 6 months

Rejection Criteria

Specimen Gel-separator tube

Test Version

17-Oct-2022

Performance / Interpretation

Method

LC-MS/MS

Turnaround Time

7 days

Results

Name Units Reference Range Conversion Factor
Imipramine ng/mL
  • No therapeutic range for Imipramine alone
Desipramine ng/mL
  • No therapeutic range for Imipramine alone
Imipramine + Desipramine ng/mL
  • Therapeutic: 175 - 300
  • Toxic: > 300
(Effective 18-Oct-2022)

Test Location

St. Michael's Hospital, 30 Bond Street, Toronto ON M5B 1W8

Test Version

17-Oct-2022

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
IMI 7576Imipramine ng/mL
7577Desipramine ng/mL
7578Combined Metabolite ng/mL

Test Version

17-Oct-2022